Summary: Using neuroimaging and fluid biomarkers from those with the familial form of frontotemporal dementia (FTD), researchers developed models of clinical and biomarker dynamics to determine the temporal sequences of biomarkers and clinical changes in f-FTD before disease progression begins.

Source: UCSF

Frontotemporal dementia (FTD), a common form of early-onset dementia, is marked by impairments in behavior, language, and sometimes motor function. Unlike Alzheimer’s Disease (AD), researchers and clinicians have been unable to accurately predict the onset of symptoms for individuals having a familial form of the condition.

While there has been significant growth in the development of therapies targeting the familial forms of frontotemporal lobe dementia (f-FTD), there is an urgent, unmet need to organize clinical trials to test these therapies due to the rarity of eligible of participants with mutations and the lack of experience with testing therapies in pre-symptomatic f-FTD mutation carriers.

Although f-FTD is rare, the genes that cause this disease are also strongly implicated in more common neurological disorders such as Alzheimer’s Disease and Amyotrophic Lateral Sclerosis, suggesting that identification of effective f-FTD treatments could speed the development of treatments for more common diseases.

Using biomarkers to lower required sample size

In a study published in Nature Medicine on September 22, 2022, University of California San Francisco researchers Adam Staffaroni, Ph.D., and Adam Boxer, MD, Ph.D., combined and harmonized clinical, neuroimaging, and fluid biomarkers from nearly all familial FTD clinical research participants across North America and Europe.

With that data, they developed models of clinical and biomarker dynamics to determine the temporal sequence of biomarker and clinical changes in f-FTD before disease progression begins.

With a sample of more than 1,000 members of familial FTD kindreds (with data from the comprehensive ALLFTD study in North America and GENFI study in Europe), they found that brain atrophy and plasma NfL elevations were measurable years prior to the onset of symptoms, paving the way for the use of these biomarkers in clinical trials of therapeutics that could prevent or delay symptoms of f-FTD.

“The models provide a roadmap for development of new biomarkers and clinical endpoints that may improve power to detect treatment effects in pre-symptomatic stages of disease,” said Boxer, endowed professor in memory and aging in the department of neurology at UCSF’s Weill Institute of Neurosciences.

“We conducted clinical trial simulations to estimate sample sizes for planning f-FTD clinical trials, and we found that using combinations of clinical and biomarker data as inclusion criteria can reduce the sample size required to detect treatment effects,” said Staffaroni, an assistant professor of neurology at UCSF.

Landmark Study of Biomarker Data May Enable Better Treatment for Early Onset Dementia

Using these models, they were able to estimate clinical trial enrollment criteria and sample sizes for clinical trials to prevent disease in asymptomatic mutation carriers or to treat disease in people who are already mildly affected. Image is in the public domain

By using multimodal models for f-FTD disease progression that included longitudinal clinical and neuropsychological scores, regional brain volumes, and plasma neurofilament light chain (NfL) in 796 carriers and 412 non-carrier controls, the researchers found that the temporal ordering of clinical and biomarker changes differed in C9orf72, GRN, and MAPT mutation carriers as individuals transitioned from asymptomatic to symptomatic disease.

Accelerating new treatments

“These results show for the first time that there are distinct changes in certain biomarkers which may help clinicians predict if and when a person who is born with an FTD gene variant will start experiencing the behavioral and cognitive problems associated with the disease,” said John K. Hsiao, MD, program director at the NIH’s National Institute on Aging.

“The results could speed the development of new treatments for this devastating disorder.”

Using these models, they were able to estimate clinical trial enrollment criteria and sample sizes for clinical trials to prevent disease in asymptomatic mutation carriers or to treat disease in people who are already mildly affected.

In prevention-trial simulations employing model-based patient selection, atrophy and NfL were the best study endpoints, whereas clinical measures were potential endpoints in early-symptomatic trials.

“These disease progression models will facilitate the planning of f-FTD clinical trials,” said Boxer. “We believe our study highlights the importance of identifying eligible trial participants outside of Europe and North America to maximize our ability to identify new effective therapies.”

About this dementia research news

Author: Press OfficeSource: UCSFContact: Press Office – UCSF
Image: The image is in the public domain

Original Research: Closed access.
“Temporal order of clinical and biomarker changes in familial frontotemporal dementia” by Adam M. Staffaroni et al. Nature Medicine


Abstract

Temporal order of clinical and biomarker changes in familial frontotemporal dementia

Unlike familial Alzheimer’s disease, we have been unable to accurately predict symptom onset in presymptomatic familial frontotemporal dementia (f-FTD) mutation carriers, which is a major hurdle to designing disease prevention trials.

We developed multimodal models for f-FTD disease progression and estimated clinical trial sample sizes in C9orf72, GRN and MAPT mutation carriers. Models included longitudinal clinical and neuropsychological scores, regional brain volumes and plasma neurofilament light chain (NfL) in 796 carriers and 412 noncarrier controls.

We found that the temporal ordering of clinical and biomarker progression differed by genotype. In prevention-trial simulations using model-based patient selection, atrophy and NfL were the best endpoints, whereas clinical measures were potential endpoints in early symptomatic trials. f-FTD prevention trials are feasible but will likely require global recruitment efforts.

These disease progression models will facilitate the planning of f-FTD clinical trials, including the selection of optimal endpoints and enrollment criteria to maximize power to detect treatment effects.

NEWS RELATED

Apple to Charge Under $100,000 for Apple Car, Launch Planned for 2026

Apple is aiming to launch an Apple-branded consumer-oriented vehicle by 2026, and its goal is to hit a price point under $100,000 to make the car appeal to a wider range of customers, reports Bloomberg. Apple initially planned to design a car that might look similar to Canoo’s Lifestyle Vehicle, ...

View more: Apple to Charge Under $100,000 for Apple Car, Launch Planned for 2026

Chronological Age, Biological Age and Gender Affect the Shrinkage of Different Brain Areas

Summary: Functional brain networks and brain shrinkage are affected in different ways by age, gender, and blood-immune factors. Source: Buck Institute Humans lose brain volume as they age, at an estimated rate of 5% per decade after age 40. But that estimate obscures the role that individual physiology plays in ...

View more: Chronological Age, Biological Age and Gender Affect the Shrinkage of Different Brain Areas

7 home heating mistakes that are costing you money – without you even realizing it

Stay warm and toasty inside even when it’s frosty outside — Canadian Tire has what you need to Take On Winter, so you can be ready for anything. From helpful home heating tips to simple baking recipes that are sure to wow, we’re here to help you embrace cozy ...

View more: 7 home heating mistakes that are costing you money – without you even realizing it

Use of Hearing Aids and Cochlear Implants Associated With a Decreased Risk of Developing Dementia

Summary: In those with hearing loss, using hearing aids or cochlear implants was associated with a long-term reduction of cognitive decline by 19% and a 3% improvement in cognitive test scores. Source: Alzheimer’s Research UK Researchers have published findings which suggest that the use of hearing aids and cochlear implants ...

View more: Use of Hearing Aids and Cochlear Implants Associated With a Decreased Risk of Developing Dementia

Can adults get Strep A? Cases rise across UK as nine children die from infection

Nine children have now died from Strep A amidst a growing number of infections in recent weeks. On Monday, a primary school student in Belfast passed away after being diagnosed with a severe form of Strep A. Stella-Lily McCorkindale was a “bright and talented little girl”, devastated staff at ...

View more: Can adults get Strep A? Cases rise across UK as nine children die from infection

Thousands of ambulance workers will go on strike just days before Christmas in bitter pay row

THOUSANDS of ambulance workers will go on strike just days before Christmas in a bitter pay row — raising fears that lives will be put at risk. Some 25,000 paramedics and emergency staff from all except two ambulance services in England are set to walk out on December 21. ...

View more: Thousands of ambulance workers will go on strike just days before Christmas in bitter pay row

Eating ultraprocessed food could increase dementia risk, study warns

Burgers, hot dogs and frozen pizza can affect your brain as well as your waistline (PA Archive) Regularly eating ultraprocessed food as a fifth or more of your daily calorie intake could increase your risk of contracting dementia, a new study has warned. Preserving congitive function may mean doing ...

View more: Eating ultraprocessed food could increase dementia risk, study warns

My daughter was hit by deadly Strep A but the hospital ran out of life-saving medicine to treat her – I was terrified

A MUM has revealed a hospital ran out of life-saving medicine to treat her sick daughter who was hit by Strep A. NHS staff told Victoria Hoult they did not have a basic antibiotic prescribed for nine-year-old Ella. Victoria Hoult was told by NHS staff that they didn't have ...

View more: My daughter was hit by deadly Strep A but the hospital ran out of life-saving medicine to treat her – I was terrified

Man hails success of first UK double lung transplant for Covid complications

Wrap Up Your Holiday Shopping With Our Exclusive Apple Accessory Sales at Nomad, Satechi, Twelve South, and More

Panel calls for stronger leadership of FDA foods program

Some schools close to stem flu outbreaks -- but is it a good long-term solution?

Apple Car Project Scaled Back and Delayed, Won't Feature Full Self-Driving Capabilities

Strep A concerns create ‘carnage’ and ‘eyewatering demand’ for the NHS

Kristin Cavallari stuns in blue faux leather dress: 'Cinderella vibes!'

Drug deaths among pregnant women hit a record high

Shocking moment terminal cancer patient, 85, forced to wait on ground for ambulance for seven hours during downpour

First UK double lung transplant for a Covid infection ‘success’

Scientists finally work out why you’re more likely to get a cold in the winter

This heated blanket is 'perfect for Canadian winters' — and it's on sale on Amazon

OTHER NEWS

Breaking thailand news, thai news, thailand news Verified News Story Network